Phase II clinical trial to study the safety and efficacy of combined S-1 + oxaliplatin therapy as neoadjuvant chemotherapy for locally advanced gastric cancer in older patients.

Mitsuhiko OtaHiroshi SaekiHideo UeharaYoshiko MatsudaSatoshi TsutsumiTetsuya KusumotoHisateru YasuiYasunari UbukataShohei YamaguchiHiroyuki OritaNaoki IzawaSaburo KakizoeMototsugu ShimokawaTomoharu YoshizumiYoshihiro KakejiMasaki MoriEiji Oki

Published in: International journal of clinical oncology (2023)

is a feasible therapy for older patients, although systemic management and careful monitoring of adverse events are necessary.

Keyphrases

phase ii
neoadjuvant chemotherapy
clinical trial
open label
locally advanced
lymph node
sentinel lymph node
phase iii
double blind
squamous cell carcinoma
placebo controlled
stem cells
early stage